Nice quick read on periop RA management. Suspect we’re treating the surgeon more than the pt. by holding bioDMARDS, but observational data supports increased infxn risk and this algorithm seems reasonable Most of this applies to other rheum dx as well https://t.co/it6CqdKmTo https://t.co/UFe1mB2vhs